Telehealth model versus in-person standard care for persons with type 1 diabetes treated with multiple daily injections: an open-label randomized controlled trial

OBJECTIVE: Increasing evidence indicates that the telehealth (TH) model is noninferior to the in-person approach regarding metabolic control in type 1 diabetes (T1D) and offers advantages such as a decrease in travel time and increased accessibility for shorter/frequent visits. The primary aim of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballesta, Sílvia, Chillarón, Juan J., Inglada, Yolanda, Climent, Elisenda, Llauradó, Gemma, Pedro-Botet, Juan, Cots, Francesc, Camell, Helena, Flores, Juana A., Benaiges, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333924/
https://www.ncbi.nlm.nih.gov/pubmed/37441496
http://dx.doi.org/10.3389/fendo.2023.1176765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333924/
https://www.ncbi.nlm.nih.gov/pubmed/37441496
http://dx.doi.org/10.3389/fendo.2023.1176765

Ejemplares similares